Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)

Review decision - March 2015 information

Appendix A - RPP decision paper March 2015

Appendix A - RPP decision paper March 2015 (PDF 72 KB)

Colorectal cancer (metastatic) - panitumumab (terminated appraisal): review proposal 9 February 2015 information

Colorectal cancer (metastatic)- panitumumab (terminated appraisal): appendix A matrix of stakeholders

Colorectal cancer (metastatic)- panitumumab (terminated appraisal): appendix A matrix of stakeholders (PDF 101 KB)

Colorectal cancer (metastatic)- panitumumab (terminated appraisal): appendix B - GE proposal paper January 2015

Colorectal cancer (metastatic)- panitumumab (terminated appraisal): appendix B - GE proposal paper January 2015 (PDF 621 KB)

TA176 Colorectal cancer (first line) - cetuximab and TA240 Colorectal cancer (metastatic) - panitumumab (terminated appraisal): review decision - January 2014 information

TA176 and TA240; Cetuximab and Panitumumab for the first-line treatment of metastatic colorectal cancer: appendix A - GE Decision Paper - January 2014

Colorectal cancer (metastatic) - panitumumab: letter to stakeholders about suspension